{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:21:52Z","timestamp":1784866912807,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["405655\/2023-1"],"award-info":[{"award-number":["405655\/2023-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["305626\/2022-1"],"award-info":[{"award-number":["305626\/2022-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018809","name":"Universidade Federal de Pelotas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Foundation for Research Support of Rio Grande do Sul State","doi-asserted-by":"publisher","award":["21\/2551-0000614-5"],"award-info":[{"award-number":["21\/2551-0000614-5"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Foundation for Research Support of Rio Grande do Sul State","doi-asserted-by":"publisher","award":["21\/2551-0000728-1"],"award-info":[{"award-number":["21\/2551-0000728-1"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbr.2024.115390","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T16:47:43Z","timestamp":1733503663000},"page":"115390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring the contribution of the dopaminergic and noradrenergic systems in the antidepressant-like action of 1-(2-(4-(4-ethylphenyl)-1H-1,2,3-triazol-1-yl)phenyl)ethanone in mice"],"prefix":"10.1016","volume":"480","author":[{"given":"Marcelo Heinemann","family":"Presa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia Juciele","family":"da Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kauane Nayara Bahr","family":"Ledebuhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narryman Pinto","family":"Zuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta\u00eds Barcelos","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiani Folharini","family":"Bortolatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0814-0203","authenticated-orcid":false,"given":"C\u00e9sar Augusto","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbr.2024.115390_bib1","first-page":"27","article-title":"F\u00e1rmacos antidepressivos: preval\u00eancia, perfil e conhecimento da popula\u00e7\u00e3o usu\u00e1ria","volume":"2","author":"da Cruz","year":"2020","journal-title":"Braz. J. Health Pharm."},{"issue":"3","key":"10.1016\/j.bbr.2024.115390_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.encep.2016.03.012","article-title":"The pharmacological basis of the serotonin system: Application to antidepressant response","volume":"42","author":"David","year":"2016","journal-title":"L'Encephale"},{"issue":"16","key":"10.1016\/j.bbr.2024.115390_bib3","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.3390\/ijms22169015","article-title":"5-HT receptors and the development of new antidepressants","volume":"22","author":"\u015alifirski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115390_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107494","article-title":"A hypothesis of monoamine (5-HT)\u2013glutamate\/GABA long neural circuit: aiming for fast-onset antidepressant discovery","volume":"208","author":"Li","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"10161","key":"10.1016\/j.bbr.2024.115390_bib5","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Course and prognosis","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2024.115390_bib6","first-page":"1","article-title":"Benzimidazole-1, 2, 3-triazole-piperazine hybrids: design, synthesis, antidiabetic evaluation and molecular modelling studies","author":"Deswal","year":"2022","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bbr.2024.115390_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132469","article-title":"A review on synthesis, mechanism of action, and structure-activity relationships of 1, 2, 3-triazole-based \u03b1-glucosidase inhibitors as promising anti-diabetic agents","author":"Fallah","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbr.2024.115390_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104835","article-title":"Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7\/HepG2 cytotoxicity: synthesis, EGFR inhibitory effect, and metabolic stability","volume":"111","author":"Ihmaid","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbr.2024.115390_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104133","article-title":"Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1, 2, 3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses","volume":"103","author":"Rezki","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbr.2024.115390_bib10","first-page":"177","article-title":"Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: the role of blood-brain barrier permeability, NF-\u03baB signaling, and microglial activation","volume":"99","author":"Fronza","year":"2022","journal-title":"Brain\u00a0Behav.\u00a0Immun."},{"key":"10.1016\/j.bbr.2024.115390_bib11","first-page":"1","article-title":"QTC-4-MeOBnE ameliorated depressive-like behavior and memory impairment in 3xTg mice","author":"Fronza","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2024.115390_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130369","article-title":"Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: an updated review","volume":"1237","author":"Singh","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"2","key":"10.1016\/j.bbr.2024.115390_bib13","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1039\/D0NJ04735J","article-title":"Synthesis of 2\u2032-(1, 2, 3-triazoyl)-acetophenones: molecular docking and inhibition of in vitro monoamine oxidase activity","volume":"45","author":"Costa","year":"2021","journal-title":"N. J. Chem."},{"key":"10.1016\/j.bbr.2024.115390_bib14","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.3c00108","article-title":"Antidepressant-like Effect of 1-(2-(4-(4-Ethylphenyl)-1H-1, 2, 3-triazol-1-yl) phenyl) ethan-1-one in Mice: evidence of the Contribution of the Serotonergic System","author":"Presa","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbr.2024.115390_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","article-title":"Dopamine in Parkinson's disease","volume":"522","author":"Latif","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"9-11","key":"10.1016\/j.bbr.2024.115390_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.lfs.2013.07.024","article-title":"Involvement of the dopaminergic and serotonergic systems in the antidepressant-like effect caused by 4-phenyl-1-(phenylselanylmethyl)-1, 2, 3-triazole","volume":"93","author":"Donato","year":"2013","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.bbr.2024.115390_bib17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.pnpbp.2008.01.012","article-title":"Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test","volume":"32","author":"Lobato","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2024.115390_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2015.10.008","article-title":"Involvement of monoaminergic system in the antidepressant-like effect of (octylseleno)-xylofuranoside in the mouse tail suspension test","volume":"65","author":"Brod","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2024.115390_bib19","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1007\/s00213-021-05921-9","article-title":"2-Phenyl-3-(phenylselanyl) benzofuran elicits acute antidepressant-like action in male Swiss mice mediated by modulation of the dopaminergic system and reveals therapeutic efficacy in both sexes","volume":"238","author":"da Silva","year":"2021","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2024.115390_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.bbr.2024.115390_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2024.115390_bib22","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. De. Pharmacodyn. Et. De. Ther."},{"key":"10.1016\/j.bbr.2024.115390_bib23","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00213-020-05600-1","article-title":"Antidepressant-like effect of a selenopropargylic benzamide in mice: involvement of the serotonergic system","volume":"237","author":"Besckow","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2024.115390_bib24","first-page":"1","article-title":"Involvement of the serotonergic system in the antidepressant-like effect of 1-(phenylselanyl)-2-(p-tolyl) indolizine in mice","author":"da Rocha","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2024.115390_bib25","article-title":"Insights into serotonergic and antioxidant mechanisms involved in antidepressant-like action of 2-phenyl-3-(phenylselanyl) benzofuran in mice","volume":"102","author":"Gall","year":"2020","journal-title":"Prog. Neuro\u00a0Psychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbr.2024.115390_bib26","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acschemneuro.2c00129","article-title":"Antidepressant-like effect of a selenoindolizine in mice: in vivo and in silico evidence for the involvement of the serotonergic 5-HT2A\/C receptors","volume":"13","author":"Garcia","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"11","key":"10.1016\/j.bbr.2024.115390_bib27","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/0006-2952(65)90025-0","article-title":"A rapid microfluorimetric determination of monoamine oxidase","volume":"14","author":"Krajl","year":"1965","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbr.2024.115390_bib28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0024-3205(01)01178-X","article-title":"Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals potential implications in relation to oxidative stress","volume":"69","author":"Soto-Otero","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2024.115390_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fnmol.2020.00067","article-title":"D1 dopamine receptor activation induces neuronal eEF2 pathway-dependent protein synthesis","volume":"13","author":"David","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbr.2024.115390_bib30","article-title":"Dopamine receptors: is it possible to become a therapeutic target for depression","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbr.2024.115390_bib31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/0269881120959613","article-title":"Selective activation of D1 dopamine receptors exerts antidepressant-like activity in rats","volume":"34","author":"Desormeaux","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2024.115390_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0269881119827889","article-title":"The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression","volume":"33","author":"Papp","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.bbr.2024.115390_bib33","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41401-021-00854-7","article-title":"Antidepressant-like effects of cinnamamide derivative M2 via D2 receptors in the mouse medial prefrontal cortex","volume":"43","author":"Che","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbr.2024.115390_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107836","article-title":"Oxytocin exerts antidepressant-like effect by potentiating dopaminergic synaptic transmission in the mPFC","volume":"162","author":"Li","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2024.115390_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1176\/appi.ajp.2016.16010111","article-title":"Dopaminergic enhancement of striatal response to reward in major depression","volume":"174","author":"Admon","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2024.115390_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104730","article-title":"A selective D2 dopamine receptor agonist alleviates depression through up-regulation of tyrosine hydroxylase and increased neurogenesis in hippocampus of the prenatally stressed rats","volume":"136","author":"Fatima","year":"2020","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.bbr.2024.115390_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ijnp\/pyac082","article-title":"Rasd2 mediates acute fasting-induced antidepressant-like effects via dopamine D2 receptor activation in ovariectomized mice","volume":"26","author":"Cheng","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.bbr.2024.115390_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jphs.2018.06.006","article-title":"Antidepressant-like effect of aripiprazole via 5-HT1A, D1, and D2 receptors in the prefrontal cortex of olfactory bulbectomized mice","volume":"137","author":"Takahashi","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"24","key":"10.1016\/j.bbr.2024.115390_bib39","doi-asserted-by":"crossref","first-page":"9532","DOI":"10.3390\/ijms21249532","article-title":"Mechanism of action of atypical antipsychotic drugs in mood disorders","volume":"21","author":"Grinchii","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2024.115390_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2018.05.035","article-title":"Monoaminergic and aminoacidergic receptors are involved in the antidepressant-like effect of ginsenoside Rb1 in mouse hippocampus (CA3) and prefrontal cortex","volume":"1699","author":"Wang","year":"2018","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbr.2024.115390_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/FBP.0000000000000605","article-title":"The \u03b11-adrenergic receptors in the amygdala regulate the induction of learned despair through protein kinase C-beta signaling","volume":"32","author":"Fujita","year":"2021","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2024.115390_bib42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainresbull.2021.11.005","article-title":"Tamsulosin facilitates depressive-like behaviors in mice: involvement of endogenous glucocorticoids","volume":"178","author":"Holanda","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"10","key":"10.1016\/j.bbr.2024.115390_bib43","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41386-018-0024-x","article-title":"Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety-and depression-related behaviors in mice","volume":"43","author":"Mineur","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.bbr.2024.115390_bib44","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41386-019-0334-7","article-title":"\u03b21-adrenergic receptors mediate plasma acyl-ghrelin elevation and depressive-like behavior induced by chronic psychosocial stress","volume":"44","author":"Gupta","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2024.115390_bib45","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fphar.2019.01000","article-title":"Salmeterol, a \u03b22 adrenergic agonist, promotes adult hippocampal neurogenesis in a region-specific manner","volume":"10","author":"Bortolotto","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"33","key":"10.1016\/j.bbr.2024.115390_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117903119","article-title":"Noradrenaline activation of hippocampal dopamine D1 receptors promotes antidepressant effects","volume":"119","author":"Kobayashi","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2024.115390_bib47","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jad.2021.01.021","article-title":"Revisiting monoamine oxidase inhibitors for the treatment of depressive disorders: a systematic review and network meta-analysis","volume":"282","author":"Suchting","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbr.2024.115390_bib48","first-page":"1","article-title":"The prescriber\u2019s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression","author":"Van den Eynde","year":"2022","journal-title":"CNS Spectr."},{"issue":"3","key":"10.1016\/j.bbr.2024.115390_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/cbdd.13654","article-title":"Monoamine oxidase inhibition by selected dye compounds","volume":"95","author":"Beer","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbr.2024.115390_bib50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00702-017-1709-8","article-title":"Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis","volume":"125","author":"Naoi","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2024.115390_bib51","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00702-018-1881-5","article-title":"90 years of monoamine oxidase: some progress and some confusion","volume":"125","author":"Tipton","year":"2018","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2024.115390_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbr.2024.115390_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1017\/S1461145712001496","article-title":"On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal","volume":"17","author":"Millan","year":"2014","journal-title":"Int J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2024.115390_bib54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2017.09.023","article-title":"Antidepressant-like effect of gallic acid in mice: dual involvement of serotonergic and catecholaminergic systems","volume":"190","author":"Can","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2024.115390_bib55","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pbb.2014.04.005","article-title":"Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice","volume":"122","author":"Ludka","year":"2014","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.bbr.2024.115390_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113066","article-title":"Potential antidepressant-like effect of piperazine derivative LQFM212 in mice: role of monoaminergic pathway and brain-derived neurotrophic factor","volume":"401","author":"Moreira","year":"2021","journal-title":"Behav. Brain Res"},{"issue":"19","key":"10.1016\/j.bbr.2024.115390_bib57","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.3390\/ijms20194827","article-title":"Selecting an appropriate animal model of depression","volume":"20","author":"Hao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2024.115390_bib58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00441-018-2973-0","article-title":"Animal models of depression: pros and cons","volume":"377","author":"Harro","year":"2019","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbr.2024.115390_bib59","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","article-title":"Animal models of major depression: drawbacks and challenges","volume":"126","author":"Planchez","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2024.115390_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brainresbull.2018.09.002","article-title":"Depression and adult neurogenesis: positive effects of the antidepressant fluoxetine and of physical exercise","volume":"143","author":"Micheli","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2024.115390_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173998","article-title":"Antidepressants\u2019 effects on testosterone and estrogens: what do we know","volume":"899","author":"Pavlidi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2024.115390_bib62","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/jpm12060907","article-title":"Sex-related differences in pharmacological response to CNS drugs: a narrative review","volume":"12","author":"Romanescu","year":"2022","journal-title":"J. Pers. Med."},{"issue":"9","key":"10.1016\/j.bbr.2024.115390_bib63","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3390\/brainsci11091199","article-title":"Sex differences in dopamine receptors and relevance to neuropsychiatric disorders","volume":"11","author":"Williams","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbr.2024.115390_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.838122","article-title":"Sex differences in depression-like behaviors in adult mice depend on endophenotype and strain","volume":"16","author":"Pitzer","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2024.115390_bib65","unstructured":"WHO, World Health Organization, Depression, ed, 2022."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432824005461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432824005461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T07:49:56Z","timestamp":1739173796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432824005461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":65,"alternative-id":["S0166432824005461"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2024.115390","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the contribution of the dopaminergic and noradrenergic systems in the antidepressant-like action of 1-(2-(4-(4-ethylphenyl)-1H-1,2,3-triazol-1-yl)phenyl)ethanone in mice","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2024.115390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115390"}}